Skip to main content
. 2016 Apr 18;11(4):e0153635. doi: 10.1371/journal.pone.0153635

Fig 1. Design of the EpleCsAT: Safety trial.

Fig 1

Sequential inclusion was performed: 14 patients during step 1; then 17 new patients during step 2.